Treatment with paclitaxel 1-h infusion and carboplatin of patients with advanced non-small-cell lung cancer: A phase II multicentre trial

Lung Cancer

Volumn 24, Issue 2, 1999, Pages 107-113

  Helsing, Martin ^a   Thaning, Lars ^a   Sederholm, Christer ^b   Lamberg, Kristina ^c   Martinsson, Jan Erik ^d   Ek, Lars ^e   Månsson, Tryggve ^f   Andersson, Lars ^g   Hero, Ulf ^h   Anjedani, Dariush ⁱ   Svennson, Gunnar ^j  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d BORÅS HOSPITAL   (Sweden)

^e HELSINGBORG HOSPITAL   (Sweden)

^f Skövde Hospital   (Sweden)

^g Trollhattan Hospital   (Sweden)

^h UDDEVALLA HOSPITAL   (Sweden)

ⁱ FALUN HOSPITAL   (Sweden)

^j CENTRAL HOSPITAL   (Sweden)

more..

Author keywords

Carboplatin; Chemotherapy; Non small cell lung cancer; Paclitaxel

Indexed keywords

BETAMETHASONE; CARBOPLATIN; CIMETIDINE; CLEMASTINE; CREATININE; IOHEXOL; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG TOXICITY; EDEMA; FATIGUE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032810137     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00027-6     Document Type: Article

References (12)

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised trials. Br J Med. 311:1995.
2. Bonomi P.D., Finkelstein D.M., Ruckdeschel J.C. et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: a study of the Eastern Cooperative Group. J Clin Oncol. 7:1989;1602-1613.
3. Murphy W.K., Fossella F.V., Winn R.J. et al. Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst. 85:1993;384-388.
4. Chang A.Y., Kim K., Glick J. et al. Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results. J Natl Cancer Inst. 85:1993;388-394.
5. Hainsworth J.D., Thompson D.S., Greco F.A. Paclitaxel by 1-hour infusion: an active drug in metastatic non-small cell lung cancer. J Clin Oncol. 13:1995;1609-1614.
6. Langer C.J., Leighton J.C., Comis R.L. et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol. 13:1995;1860-1870.
7. Johnson D.H., Einhorn L.H.: Paclitaxel plus carboplatin: an effective combination chemotherapy for advanced non-small cell lung cancer or just another Elvis sighting? J Clin Oncol. 13:1995;1840-1842.
8. Hainsworth J.D., Urba W.J., Hon J.K. et al. One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial. Eur J Cancer. 5:1998;654-658.
9. Johnson D.H., Paul M.D., Hande K.R. et al. Paclitaxel plus carboplatin in advanced non-small cell lung cancer: a phase II trial. J Clin Oncol. 14:1996;2054-2060.
10. Schutte W., Bork I., Sucker S. Phase II trial of paclitaxel and carboplatin as first line treatment in advanced non-small cell lung cancer (Abstract). Proc Am Soc Clin Onc. 15:1996;1208.
11. Helsing M., Bergman B., Thaning L. et al. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomized phase III trial. Eur J Cancer. 7:1998;1036-1044.
12. Langer C., Kaplan R., Roswald E. et al. Paclitaxel by 1-hour infusion combined with carboplatin in advanced non-small cell lung carcinoma: a phase II study (Abstract). Proc Am Soc Clin Onc. 15:1996;396.